[ESPR] QoQ Quarter Result on 31-Dec-2014 [#Q4]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
10-Mar-2015
Financial Year
2014
Quarter
31-Dec-2014 [#Q4]
Profit Trend
QoQ- 3.56%
YoY- 2.39%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -12,801 -12,395 -11,466 -9,457 -9,806 -9,238 -7,874 38.21%
Tax 378 337 227 135 164 18 16 721.76%
NP -12,801 -12,395 -11,466 -9,457 -9,806 -9,238 -7,874 38.21%
Tax Rate - - - - - - - -
Total Cost 12,801 12,395 11,466 9,457 9,806 9,238 7,874 38.21%
Ratio Analysis
30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 CAGR
EPS -0.57 -0.55 -0.56 -0.49 -0.64 -0.60 -0.51 7.68%
EPS Diluted -0.57 -0.55 -0.56 -0.49 -0.64 -0.60 -0.51 7.68%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.